Biologics Commonly Used in Cutaneous Crohn's Disease

• by Andrea Surnit

• May 27, 2026

Symposium on Hidradenitis Suppurativa Advances 2025 Proceedings

• by Claire S. Chung, Kenan Kherallah, Nazrin Ashina, Gabriela E. Beraja, Anuj Budhiraja, Serena Dienes, Mollye Goldberg, Grace Xiong, Raed Alhusayen, Stephanie Goldberg, Tammy Gonzalez, Jennifer L. Hsiao, Hadar Lev-Tov, Cathryn Sibbald, Vincent Piguet, Martina Porter

• May 11, 2026

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics

• by Rocío Maseda, María Carmen Arriba, Lucía Martínez-Santamaría, Eva Jiménez, Sara Herráiz-Gil, Nuria Illera, Lucía Quintana-Castanedo, Marta García, Susana Suárez-Sancho, Rosa Yáñez, Isabel Pérez-Conde, Marta Carretero, Magdalena Martínez-Queipo, Raquel de Paz, Carlos León, Víctor Jiménez-Yuste, Alberto M. Borobia, Ángeles Vicente, Su M. Lwin, John A. McGrath, María Eugenia Fernández-Santos, Nora Butta, Rosa Sacedón, Marcela del Río, Raúl de Lucas, María José Escámez

• May 5, 2026

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

• by Kathryn Wighton

• May 20, 2026

• 5 min